<scp>MEK</scp> 1 inhibition and bleeding in hereditary haemorrhagic telangiectasia-Reference-Cited by-同舟云学术

MEK 1 inhibition and bleeding in hereditary haemorrhagic telangiectasia

Published:2023-10-23 Issue:1 Volume:204 Page:361-365
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shovlin Claire L.¹²³^ORCID,Patel Dilip¹²,Bielowka Adrianna¹²,Ledermann Jonathan A.⁴,Modarresi Atieh¹,Bernabeu‐Herrero Maria E.¹²,Aldred Micheala A.⁵^ORCID,Alsafi Ali³,

Affiliation:

1. National Heart and Lung Institute Imperial College London London UK

2. NIHR Imperial Biomedical Research Centre London UK

3. Imperial College Healthcare NHS Trust London UK

4. Department of Oncology University College London Cancer Institute London UK

5. Indiana University School of Medicine Indianapolis Indiana USA

Funder

Imperial College Healthcare NHS Trust

National Institute for Health Research

Wellcome Trust

Cancer Research UK

Medical Research Council

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19167

Reference15 articles.

1. The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care

2. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia

3. Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia

4. Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial

5. Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT;Blood;2024-05-30

2. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances;Journal of Clinical Investigation;2024-02-15

3. Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction;Journal of Clinical Medicine;2023-12-31

4. Update December 2023;Lymphatic Research and Biology;2023-12-01